Article
Transcriptomic Profiling Reveals Key Molecular Events and Pathways Driving Acquired Chemotherapy Resistance in Relapsed Acute Myeloid Leukemia
2025-12-26
Abstract excerpt
<h4>Background: </h4> Acute myeloid leukemia (AML) is a highly heterogeneous hematologic malignancy. Although induction therapy induces remission in many patients, relapse and acquired chemoresistance remain the major causes of treatment failure. Defining the molecular mechanisms underlying relapse is essential for improving therapeutic strategies. <h4>Methods:</h4> Bone marrow samples from nine AML patients were...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eddfc200-8e7d-5d4d-b245-0a4c75436c4a
- DOI
- 10.64898/2025.12.24.696467
